Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe recruitment status changed from Recruiting to Not yet recruiting. The page now lists Ovarian cancer as the condition and adds related topics, including MedlinePlus Genetics, to provide broader context.SummaryDifference0.6%

- Check11 days agoChange DetectedRemoval of the related topic links 'Ovarian cancer' and 'MedlinePlus Genetics' from the page's related topics section. This alters the navigational links but does not affect the core trial information.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page version/revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded topic: Ovarian cancer and related topic: MedlinePlus Genetics. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe ovarian cancer topic tag and the MedlinePlus Genetics related topics were removed. This could affect study categorization and access to related informational resources.SummaryDifference0.1%

- Check61 days agoChange DetectedOvarian cancer is added as a related topic and MedlinePlus Genetics is listed under related topics. The site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.